Allison E. Cherry
Impact in
- Pharmacology top 10%
- Cannabis and Cannabinoid Research
-
- Autism Spectrum Disorder Research
Papers in
- Genetics 3
- Glioma Diagnosis and Treatment 3
- Genetics and Neurodevelopmental Disorders 1
-
- Cannabis and Cannabinoid Research 3
- Co-authors
- Nephi Stella (7 shared papers)Igor Splawski (1 shared paper)David E. Clapham (1 shared paper)Mark T. Keating (1 shared paper)Dana S. Yoo (1 shared paper)Stephanie C. Stotz (1 shared paper)Susan Fung (4 shared papers)Eric A. Horne (3 shared papers)
- Journals
- Glia (2 papers)Molecular Cancer Therapeutics (1 paper)Neuroscience (1 paper)Neuro-Oncology (1 paper)Neuron (1 paper)
- Partner nations
- United StatesJapanAustria
In The Last Decade
Allison E. Cherry
10 papers receiving 469 citations
Peers
Comparison fields: 5 of 47
- Pharmacology 109
- Cognitive Neuroscience 74
- Genetics 29
- Cellular and Molecular Neuroscience 41
- Molecular Biology 151
Countries citing papers authored by Allison E. Cherry
This map shows the geographic impact of Allison E. Cherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison E. Cherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison E. Cherry more than expected).
Fields of papers citing papers by Allison E. Cherry
This network shows the impact of papers produced by Allison E. Cherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison E. Cherry. The network helps show where Allison E. Cherry may publish in the future.
Co-authors
The 25 scholars most cited alongside Allison E. Cherry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 207 | |
| 2 | 2014 | 99 | |
| 3 | 2012 | 44 | |
| 4 | 2014 | 41 | |
| 5 | 2016 | 23 | |
| 6 | 2008 | 21 | |
| 7 | 2019 | 17 | |
| 8 | 2015 | 15 | |
| 9 | 2016 | 11 | |
| 10 | 2013 | 1 |
About Allison E. Cherry
Allison E. Cherry is a scholar working on Genetics, Pharmacology, Cell Biology, Neurology and Genetics, having authored 10 papers that have together received 479 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (3 papers), Glioma Diagnosis and Treatment (3 papers), Receptor Mechanisms and Signaling (2 papers), Microtubule and mitosis dynamics (2 papers), Genetics and Neurodevelopmental Disorders (1 paper), Epilepsy research and treatment (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper) and Synthesis and biological activity (1 paper). The work is most often cited by research in Pharmacology (109 citations), Cognitive Neuroscience (74 citations), Genetics (29 citations), Cellular and Molecular Neuroscience (41 citations) and Molecular Biology (151 citations). Allison E. Cherry has collaborated with scholars based in United States, Japan and Austria. Frequent co-authors include Nephi Stella, Igor Splawski, David E. Clapham, Mark T. Keating, Dana S. Yoo, Stephanie C. Stotz, Susan Fung, Eric A. Horne, Alipi V. Naydenov and William Marrs. Their work appears in journals such as Glia, Molecular Cancer Therapeutics, Neuroscience, Neuro-Oncology and Neuron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.